Advertisement Advanced Cancer Therapeutics names new board member - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Advanced Cancer Therapeutics names new board member

Advanced Cancer Therapeutics, a biopharmaceutical company dedicated to advancing novel therapeutics for the prevention and treatment of cancer, has appointed James Ramsey to its board of directors.

Dr Ramsey has served as president of the University of Louisville since late 2002. Dr Ramsey has earned his PhD in economics from the University of Kentucky.

Dale Boden, chairman of the board at Advanced Cancer Therapeutics, said: “We are honored to have Dr Ramsey join our board of directors. Dr Ramsey brings a unique combination of economic and public policy experience which will be invaluable in guiding the company as we continue to advance our pipeline of anticancer products closer to human clinical trials.”